Literature DB >> 28771736

Characterization of primary rat nasal epithelial cultures in CFTR knockout rats as a model for CF sinus disease.

Kiranya E Tipirneni1, Do-Yeon Cho1,2, Daniel F Skinner1,2, Shaoyan Zhang1,2, Calvin Mackey1,2, Dong-Jin Lim1,2, Bradford A Woodworth1,2.   

Abstract

OBJECTIVE: The objectives of the current experiments were to develop and characterize primary rat nasal epithelial cultures and evaluate their usefulness as a model of cystic fibrosis (CF) sinonasal transepithelial transport and CF transmembrane conductance regulator (CFTR) function. STUDY
DESIGN: Laboratory in vitro and animal studies.
METHODS: CFTR+/+ and CFTR-/- rat nasal septal epithelia (RNSE) were cultured on semipermeable supports at an air-liquid interface to confluence and full differentiation. Monolayers were mounted in Ussing chambers for pharmacologic manipulation of ion transport and compared to similar filters containing murine (MNSE) and human (HSNE) epithelia. Histology and scanning electron microscopy (SEM) were completed. Real-time polymerase chain reaction of CFTR+/+ RNSE, MNSE, and HSNE was performed to evaluate relative CFTR gene expression.
RESULTS: Forskolin-stimulated anion transport (ΔIsc in μA/cm2 ) was significantly greater in epithelia derived from CFTR+/+ when compared to CFTR-/- animals (100.9 ± 3.7 vs. 10.5 ± 0.9; P < 0.0001). Amiloride-sensitive ISC was equivalent (-42.3 ± 2.8 vs. -46.1 ± 2.3; P = 0.524). No inhibition of CFTR-mediated chloride (Cl- ) secretion was exhibited in CFTR-/- epithelia with the addition of the specific CFTR inhibitor, CFTRInh -172. However, calcium-activated Cl- secretion (UTP) was significantly increased in CFTR-/- RNSE (CFTR-/- -106.8 ± 1.6 vs. CFTR+/+ -32.2 ± 3.1; P < 0.0001). All responses were larger in RNSE when compared to CFTR+/+ and CFTR-/- (or F508del/F508del) murine and human cells (P < 0.0001). Scanning electron microscopy demonstrated 80% to 90% ciliation in all RNSE cultures. There was no evidence of infection in CFTR-/- rats at 4 months. CFTR expression was similar among species.
CONCLUSION: The successful development of the CFTR-/- rat enables improved evaluation of CF sinus disease based on characteristic abnormalities of ion transport. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:E384-E391, 2017.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Keywords:  CFTR; Cystic fibrosis; Ussing chamber; chronic rhinosinusitis; chronic sinusitis; electrophysiology; ion transport; mucociliary clearance; rat nasal culture; sinusitis

Mesh:

Substances:

Year:  2017        PMID: 28771736      PMCID: PMC5654659          DOI: 10.1002/lary.26720

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  42 in total

Review 1.  Management of the upper airway in cystic fibrosis.

Authors:  Elisa A Illing; Bradford A Woodworth
Journal:  Curr Opin Pulm Med       Date:  2014-11       Impact factor: 3.155

2.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 3.  Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

Authors:  Scott D Grosse; Coleen A Boyle; Jeffrey R Botkin; Anne Marie Comeau; Martin Kharrazi; Margaret Rosenfeld; Benjamin S Wilfond
Journal:  MMWR Recomm Rep       Date:  2004-10-15

Review 4.  Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis.

Authors:  Nico Derichs
Journal:  Eur Respir Rev       Date:  2013-03-01

5.  Murine nasal septa for respiratory epithelial air-liquid interface cultures.

Authors:  Marcelo B Antunes; Bradford A Woodworth; Geeta Bhargave; Guoxiang Xiong; Jorge L Aguilar; Adam J Ratner; James L Kreindler; Ronald C Rubenstein; Noam A Cohen
Journal:  Biotechniques       Date:  2007-08       Impact factor: 1.993

6.  Relative ion permeability of normal and cystic fibrosis nasal epithelium.

Authors:  M Knowles; J Gatzy; R Boucher
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

Review 7.  What have we learned from mouse models for cystic fibrosis?

Authors:  Isabel Carvalho-Oliveira; Bob J Scholte; Deborah Penque
Journal:  Expert Rev Mol Diagn       Date:  2007-07       Impact factor: 5.225

8.  Inter-α-inhibitor blocks epithelial sodium channel activation and decreases nasal potential differences in ΔF508 mice.

Authors:  Ahmed Lazrak; Asta Jurkuvenaite; Emily C Ness; Shaoyan Zhang; Bradford A Woodworth; Marianne S Muhlebach; Vandy P Stober; Yow-Pin Lim; Stavros Garantziotis; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

9.  Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.

Authors:  Katherine L Tuggle; Susan E Birket; Xiaoxia Cui; Jeong Hong; Joe Warren; Lara Reid; Andre Chambers; Diana Ji; Kevin Gamber; Kengyeh K Chu; Guillermo Tearney; Li Ping Tang; James A Fortenberry; Ming Du; Joan M Cadillac; David M Bedwell; Steven M Rowe; Eric J Sorscher; Michelle V Fanucchi
Journal:  PLoS One       Date:  2014-03-07       Impact factor: 3.240

10.  Sinupret activates CFTR and TMEM16A-dependent transepithelial chloride transport and improves indicators of mucociliary clearance.

Authors:  Shaoyan Zhang; Daniel Skinner; Stephen Bradley Hicks; Mark O Bevensee; Eric J Sorscher; Ahmed Lazrak; Sadis Matalon; Carmel M McNicholas; Bradford A Woodworth
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

View more
  7 in total

Review 1.  The Microbiome and Chronic Rhinosinusitis.

Authors:  Do-Yeon Cho; Ryan C Hunter; Vijay R Ramakrishnan
Journal:  Immunol Allergy Clin North Am       Date:  2020-01-16       Impact factor: 3.479

Review 2.  Seeing cilia: imaging modalities for ciliary motion and clinical connections.

Authors:  Jacelyn E Peabody; Ren-Jay Shei; Brent M Bermingham; Scott E Phillips; Brett Turner; Steven M Rowe; George M Solomon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-03-01       Impact factor: 5.464

3.  Sinus hypoplasia in the cystic fibrosis rat resolves in the absence of chronic infection.

Authors:  Jessica Grayson; Kiranya E Tipirneni; Daniel F Skinner; Matthew Fort; Do-Yeon Cho; Shaoyan Zhang; Andrew C Prince; Dong-Jin Lim; Calvin Mackey; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2017-06-08       Impact factor: 3.858

4.  Assessment of acquired mucociliary clearance defects using micro-optical coherence tomography.

Authors:  Kiranya E Tipirneni; Jessica W Grayson; Shaoyan Zhang; Do-Yeon Cho; Daniel F Skinner; Dong-Jin Lim; Calvin Mackey; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2017-06-28       Impact factor: 3.858

5.  Korean Red Ginseng aqueous extract improves markers of mucociliary clearance by stimulating chloride secretion.

Authors:  Do-Yeon Cho; Daniel Skinner; Shaoyan Zhang; Ahmed Lazrak; Dong Jin Lim; Christopher G Weeks; Catherine G Banks; Chang Kyun Han; Si-Kwan Kim; Guillermo J Tearney; Sadis Matalon; Steven M Rowe; Bradford A Woodworth
Journal:  J Ginseng Res       Date:  2019-09-13       Impact factor: 6.060

6.  Assessing the consistency of iPSC and animal models in cystic fibrosis modelling: A meta-analysis.

Authors:  Toqa Darwish; Azhar Al-Khulaifi; Menatalla Ali; Rana Mowafy; Abdelilah Arredouani; Suhail A Doi; Mohamed M Emara
Journal:  PLoS One       Date:  2022-08-09       Impact factor: 3.752

7.  Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9.

Authors:  Elise Dreano; Marc Bacchetta; Juliette Simonin; Louise Galmiche; Claire Usal; Lotfi Slimani; Jérémy Sadoine; Laurent Tesson; Ignacio Anegon; Jean-Paul Concordet; Aurélie Hatton; Lucile Vignaud; Danielle Tondelier; Isabelle Sermet-Gaudelus; Marc Chanson; Charles-Henry Cottart
Journal:  Animal Model Exp Med       Date:  2019-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.